Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 10 results found. Search for [ Swedish pharmaceutical industry ]

Results 1 to 10 of 10
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites

September 27, 2020
Adar Poonawalla had earlier expressed concerns around production and distribution plans of the coronavirus vaccine. He asked if the Centre had Rs 80,000 crore available with it over next one year to distribute vaccine to Indians

July 21, 2020
Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes

Rajeev Dubey
New Delhi, December 24, 2019
In an interview with Business Today's Rajeev Dubey, AstraZeneca's Non-executive Chairman, Leif Johansson talks about how the world's 14th largest pharma company is facing multiple challenges, two of which are Brexit and the US-China trade war

December 3, 2019
Ayushman Bharat is India's national health protection scheme, which will cover over 10 crore poor and vulnerable families

February 9, 2017
With no more orders for the F-16 from the Pentagon, Lockheed plans to use its Fort Worth, Texas plant instead to produce the fifth generation F-35 Joint Strike Fighter that the United States Air Force is transitioning to.

September 29, 2016
A short drive from the bustling tech hub of Hyderabad, Medak is the heart of India's antibiotics manufacturing business: a district of about 2.5 million that has become one of the world's largest suppliers of cheap drugs to most markets, including the United States.

Natalie Grover
Bengaluru, October 29, 2015
The Wall Street Journal said that the deal could be the biggest merger in the healthcare industry in already busy year.

Ben Hirschler
London, May 27, 2014
The fight was actually lost a week earlier after an angry stand-off on Sunday May 18 in which both sides blamed each other for closing down talks on a $118 billion offer that was \"only\" about $8 billion adrift from the price AstraZeneca wanted.

Mail Today Bureau
Mumbai, April 19, 2011
Two days after acquiring Kanoria Group's chemicals business, Aditya Birla's two overseas companies - Thai Rayon Public Co Ltd and Indo Bharat Rayon acquire Swedish specialty pulp company Domsjo Fabriker.